Connect® Myeloid Disease Registry

Summary

Objectives

This Disease Registry will collect data on patient characteristics, treatment patterns
and clinical outcomes. The objective is to describe how patients with myeloid diseases
are treated; and to build a knowledge base regarding the effectiveness and safety of
first line and subsequent treatment regimens in both community and academic settings.
Enrolled patients will receive treatment and evaluations for their disease according to
the standard of care and routine clinical practice at each study site. All treatments
that patients receive for their disease will be recorded, including initial treatment and
any subsequent therapy. Data on treatment outcomes, including response rates as measured
by the treating physician, evidence of progression, survival, and patient-reported
outcomes will be collected quarterly on the electronic CRF.